CHLOE HOMEN: Open Payments
NPI 1558012559 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,520 in 184 payments from 25 companies in 2025. Trend: 2023 $619 · 2024 $1,105 · 2025 $3,520
Food & beverage: $3,520
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $465 |
| Amgen Inc. | 27 | $454 |
| UCB, Inc. | 20 | $383 |
| AstraZeneca Pharmaceuticals LP | 18 | $308 |
| GlaxoSmithKline, LLC. | 15 | $267 |
| PFIZER INC. | 9 | $165 |
| Janssen Biotech, Inc. | 9 | $152 |
| E.R. Squibb & Sons, L.L.C. | 11 | $145 |
| ANI Pharmaceuticals, Inc. | 7 | $135 |
| Actelion Pharmaceuticals US, Inc. | 5 | $123 |
Products named: Bimzelx, SKYRIZI, SAPHNELO, BENLYSTA, TAVNEOS, RINVOQ, ORENCIA, KRYSTEXXA.
Industry payments across TX — which companies pay providers there.
